271
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Implication of epitranscriptomics in trained innate immunity and COVID-19

ORCID Icon & ORCID Icon
Pages 1077-1080 | Received 13 Jun 2021, Accepted 21 Jun 2021, Published online: 06 Jul 2021

References

  • World Health Organization (2021). www.who.int/emergencies/diseases/novel-coronavirus-2019
  • Netea MG , Domínguez-AndrésJ , BarreiroLBet al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol.20(6), 375–388 (2020).
  • Mantovani A , NeteaMG. Trained innate immunity, epigenetics, and Covid-19. N. Engl. J. Med.383(11), 1078–1080 (2020).
  • Paramasivam A , MeenaAK , VenkatapathiCet al. Novel biallelic NSUN3 variants cause early-onset mitochondrial encephalomyopathy and seizures. J. Mol. Neurosci.70(12), 1962–1965 (2020).
  • Castro de Moura M , DavalosV , Planas-SerraLet al. Epigenome-wide association study of COVID-19 severity with respiratory failure. EBioMedicine66, 103339 (2021).
  • Shulman Z , Stern-GinossarN. The RNA modification N6-methyladenosine as a novel regulator of the immune system. Nat. Immunol.21(5), 501–512 (2020).
  • Paramasivam A , PriyadharsiniJV , RaghunandhakumarS. Implications of m6A modification in autoimmune disorders. Cell. Mol. Immunol.17(5), 550–551 (2020).
  • Paramasivam A , PriyadharsiniJV. Novel insights into m6A modification in circular RNA and implications for immunity. Cell. Mol. Immunol.17(6), 668–669 (2020).
  • Paramasivam A , PriyadharsiniJV , RaghunandhakumarS. N6-adenosine methylation (m6A): a promising new molecular target in hypertension and cardiovascular diseases. Hypertens. Res.43(2), 153–154 (2020).
  • Anitha R , ParamasivamA , Vijayashree PriyadharsiniJet al. The m6A readers YTHDF1 and YTHDF3 aberrations associated with metastasis and predict poor prognosis in breast cancer patients. Am. J. Cancer Res.10(8), 2546–2554 (2020).
  • Paramasivam A , PriyadharsiniJV. Epigenetic modifications of RNA and their implications in antiviral immunity. Epigenomics12(19), 1673–1675 (2020).
  • Wang H , HuX , HuangMet al. Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation. Nat. Commun.10(1), 1898 (2019).
  • Zhang X , HaoH , MaLet al. Methyltransferase-like 3 modulates severe acute respiratory syndrome coronavirus-2 RNA N6-methyladenosine modification and replication. bioRxiv doi:10.1101/2020.10.14.338558 (2020).
  • Atlante S , MongelliA , BarbiVet al. The epigenetic implication in coronavirus infection and therapy. Clin. Epigenetics12(1), 156 (2020).
  • Wu C , ChenW , HeJet al. Interplay of m6A and H3K27 trimethylation restrains inflammation during bacterial infection. Sci. Adv.6(34), doi:10.1126/sciadv.aba0647 (2020).
  • Huang H , WengH , ZhouKet al. Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally. Nature567(7748), 414–419 (2019).
  • Liu J , DouX , ChenCet al. N 6-methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription. Science367(6477), 580–586 (2020).
  • Li Y , XiaL , TanKet al. N6-Methyladenosine co-transcriptionally directs the demethylation of histone H3K9me2. Nat. Genet.52(9), 870–877 (2020).
  • Xu W , LiJ , HeCet al. Mettl3 regulates heterochromatin in mouse embryonic stem cells. Nature591(7849), 317–321 (2021).
  • Yao Y , BiZ , WuRet al. Mettl3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBPβ pathway an mA-YTHDF2-dependent manner. FASEB J.33(6), 7529–7544 (2019).
  • Netea MG , Giamarellos-BourboulisEJ , Domínguez-AndrésJet al. Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection. Cell181(5), 969–977 (2020).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.